HOME >> BIOLOGY >> NEWS
Neural stem cells derived from human embryonic stem cells carry abnormal gene expression

Neural stem cells grown from one of the federally approved human embryonic stem cell lines proved to be inferior to neural stem cells derived from fetal tissue donated for research, a UCLA study has found.

Researchers from the Institute for Stem Cell Biology and Medicine at UCLA coaxed cells from the federally approved line to differentiate into neural stem cells, a process that might one day be used to grow replacement cells to treat such debilitating diseases as Parkinson's and Alzheimer's. However, the neural stem cells expressed a lower level of a metabolic gene called CPT 1A, a condition that causes hypoglycemia in humans.

The study may shed new light on better ways to grow neural and other stem cells in the lab so they mirror normal cells and promote normal functioning, said Guoping Fan, an assistant professor of human genetics and a researcher in UCLA's stem cell institute. The study appears this week in an early online edition of the journal Human Molecular Genetics.

"This study is a very important first step in looking at the differentiation process in neural stem cells," said Fan, senior author of the study. "Now we have a direct measurement of the types of cells that eventually, we hope, will be used for transplantation. We can tell, are they normal or not. Understanding why these cells under-expressed CPT 1A is the first step in a comprehensive understanding of cells obtained from human embryonic stem cells."

The study, Fan said, deals with one of the most important aspects in stem cell biology - potential abnormalities in cells derived from human embryonic stem cells. Stem cells with abnormalities may not effectively treat the diseases they were created to treat, or they may result in secondary problems such as hypoglycemia, Fan said.

UCLA researchers also compared the neural stem cells they grew to cancer cells to ensure that the neural stem cells did not have any abnormalities in a DNA modific
'"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
4-Aug-2006


Page: 1 2 3

Related biology news :

1. Neural stem cells lend the brain a surprising capacity for self-repair
2. Neural stem cell gene plays crucial role in eye development
3. Neural stem cells are long-lived
4. Neural tube defects decrease with folic acid fortification
5. Neural activity reveals continuity between infant and adult sleep
6. Neural crest stem cells in skin could provide alternative to embryonic stem cell use
7. Newly created cancer stem cells could aid breast cancer research
8. ESF EURYI award winner aims to stop cancer cells reading their own DNA
9. OHSU turns mouse into factory for human liver cells
10. UCLA scientists produce functioning neurons from human embryonic stem cells
11. UCF research links proteins, stem cells and potential Alzheimers treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... ... In the development of biosimilars, the broad definition of the similarity concept in ... several manufacturers have been successful and numerous follow-on biologics are approved in the US ... analytical similarity is achieved in biosimilars based on recently approved products in the US. ...
(Date:3/27/2019)... ATLANTA (PRWEB) , ... March 26, 2019 , ... ... firm Greenberg Traurig, LLP , was a panelist at the National Academy of ... at NAS’ Keck Center. Holden, a member of the firm’s award-winning Pharmaceutical, Medical ...
(Date:3/25/2019)... ... March 25, 2019 , ... Researchers have found multiple applications ... it came into use by the scientific community. Keck Graduate Institute (KGI) Assistant ... to combine the power of CRISPR’s nucleic acid targeting with the ultra sensitivity ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... (Konica Minolta) today announced the formation of their inaugural Scientific Advisory Board. ... precision medicine that takes into account individual variability in genes, environment, and lifestyle ...
(Date:3/19/2019)... ... March 19, 2019 , ... ... largest hospital in Israel and the Middle East region, and Swiss-based CDMO ... Cocoon™ manufacturing platform. The partnership will enable Sheba to vastly streamline its ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM ... allow life science companies to easily comply with FDA 21 CFR Part 11 and ... a managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... ... for their facility in Oklahoma City, OK. EyeCRO joins the Department of Veterans ... Oklahoma Health Sciences Center as the fifth institution in Oklahoma to receive this ...
Breaking Biology Technology:
Cached News: